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The mitochondrial genome relies heavily on post-
transcriptional events for its proper expression, and
misregulation of this process can cause mitochon-
drial genetic diseases in humans. Here, we report
that a novel translational variant of Fas-activated
serine/threonine kinase (FASTK) co-localizes with
mitochondrial RNA granules and is required for the
biogenesis of ND6 mRNA, a mitochondrial-encoded
subunit of the NADH dehydrogenase complex (com-
plex I). We show that ablating FASTK expression in
cultured cells and mice results specifically in loss of
ND6 mRNA and reduced complex I activity in vivo.
FASTK binds at multiple sites along the ND6 mRNA
and its precursors and cooperates with the mito-
chondrial degradosome to ensure regulated ND6
mRNA biogenesis. These data provide insights into
the mechanism and control of mitochondrial RNA
processing within mitochondrial RNA granules.INTRODUCTION
Mitochondria play a central role in the production of ATP through
oxidative phosphorylation, a process that requires five large pro-
tein complexes (complex I–V) located at the inner mitochondrial
membrane. Close to 100 proteins participate in the respiratory
chain, and whereas most of these are encoded in the nucleus
and imported into mitochondria from the cytoplasm, 13 proteins
are encoded within the mitochondrial genome. In addition to the
protein components of the respiratory chain, the mitochondrial
genome also encodes two rRNAs and 22 tRNAs required for
translation of the mitochondrial-encoded proteins. Mutations
in many of the genes encoding these proteins have been as-
sociated with severe human pathologies for which no cure1110 Cell Reports 10, 1110–1121, February 24, 2015 ª2015 The Authcurrently exists (Chinnery and Hudson, 2013). Mitochondrial
transcription is initiated from the ‘‘D-loop’’ region of the mito-
chondrial genome and gives rise to long polycistronic precursor
transcripts that span almost the entire mitochondrial genome
(reviewed in Ha¨llberg and Larsson, 2014). After transcription,
the primary transcripts are processed to yield individual mature
RNAs, in most cases by removal of flanking tRNAs according to
the tRNA punctuation model (Ojala et al., 1981). However, this
model does not completely explain how every mRNA is excised
from the polycistronic transcript because atypical junctions exist
that lack flanking tRNAs. Four such atypical junctions are found
in the human mitochondrial genome: (1) at the 30 end of the
COX1mRNA; (2) between the ATP8/6 and COX3mRNAs; (3) be-
tween the ND5 and CYB mRNAs; and (4) at the 30 end of ND6
mRNA (for a map of the mitochondrial genome, see Figures
6C and S5A). The heavy-strand-encoded mitochondrial RNAs
exist predominantly as mono- or bicistronic RNAs, whereas
ND6 mRNA, the only mRNA encoded by the light strand, is pre-
sent at steady state in both the mature form of 1.0–1.1 kb and as
several higher-molecular-weight precursor RNAs called RNA1–3
(Ojala et al., 1981). The wide variation in steady-state levels of
the mature mitochondrial RNAs that originate from both the
heavy- and light-strand polycistronic precursors underlines the
importance of post-transcriptional regulatory mechanisms in
controlling the stability and metabolism of the individual mito-
chondrial transcripts (Temperley et al., 2010; Rackham et al.,
2012).
We and others have recently observed the presence of RNA
granules within mitochondria (Antonicka et al., 2013; Borowski
et al., 2013; Jourdain et al., 2013). These mitochondrial RNA
granules have been shown to be associated with proteins that
are functionally linked to the post-transcriptional regulation of
mitochondrial RNAs, such as RNase P, RNase Z, and GRSF1
involved in RNA processing (Antonicka et al., 2013; Jourdain
et al., 2013; Bogenhagen et al., 2014); the mitochondrial polynu-
cleotide phosphorylase (PNPase)-hSuv3p helicase complex, or
mitochondrial degradosome known to degrade the so-calledors
‘‘mirror’’ RNAs complementary to the mitochondrial genes
(Szczesny et al., 2010; Borowski et al., 2013); the mitochondrial
poly(A) polymerase (Wilson et al., 2014); and RNA methyltrans-
ferases (Vilardo et al., 2012; Jourdain et al., 2013; Lee et al.,
2013). The presence of these enzymes in RNA granules therefore
suggests a role for this novel mitochondrial compartment in
post-transcriptional regulation of mitochondrial RNA expression
and turnover.
In an effort to identify new mitochondrial RNA granule compo-
nents, the protein FASTK (Fas-activated serine/threonine kinase)
caught our attention because (1) it is likely to be mitochondrial
(Pagliarini et al., 2008), (2) it binds RNA (Castello et al., 2012),
and (3) it is known to be a component of cytosolic RNA granules
(Kedersha et al., 2005). FASTK had initially been described as a
kinase activated by Fas signaling (Tian et al., 1995), but the argu-
ments in favor of this activity have been recently questioned and
this protein should no longer be considered as a kinase (Simarro
et al., 2007). We now know that FASTK regulates alternative
splicing in the nucleus and co-localizes with stress granules
and processing bodies (P-bodies), two types of cytosolic RNA
granules (Kedersha et al., 2005; Simarro et al., 2007). FASTK
knockout (FASTK/) mice have been generated, and analysis
of their immune system revealed that FASTK promotes neutro-
phil recruitment and inflammation (Simarro et al., 2010a). Which
of the putative functions and sites of action of FASTK accounts
for the phenotype of FASTK/ mice is currently unknown.
In humans, FASTK is the founding member of a family of pro-
teins, which, in addition to FASTK itself, contains five additional
members called FASTKD1–FASTKD5 (Figure S1A). All FASTKDs
are characterized by an N-terminal mitochondrial-targeting sig-
nal (Simarro et al., 2010b) and the presence of three conserved
but largely uncharacterized domains called FAST_1, FAST_2,
and RAP (Figure S1A). According to homology predictions, the
60-amino-acid RAP domain is likely to bind RNA (Lee and
Hong, 2004), and indeed, all members of the FASTK family
have recently been found in screens for RNA-binding proteins
(Baltz et al., 2012; Castello et al., 2012; Wolf and Mootha,
2014). The function of the FASTK family members in mitochon-
dria has not been studied in detail, although pioneering work
from Simarro et al. (2010b) has shown that FASTKD3 is required
for mitochondrial oxygen consumption. Interestingly, FASTKD2
has been found to bemutated in two siblings from a consanguin-
eous Bedouin family, leading to infantile mitochondrial encepha-
lomyopathy (Ghezzi et al., 2008). The precise mechanism under-
lying the pathology associated with the FASTKD2 mutation
remains to be established.
Here, we investigate the mitochondrial localization and mech-
anism of action of FASTK. We report that, in addition to its
previously reported dual cytosolic and nuclear localization,
FASTK is also able to enter themitochondria by virtue of a cryptic
mitochondrial-targeting sequence that initiates at an alternative
internal methionine. We show that FASTK is concentrated in
mitochondrial RNA granules and that it functions to regulate spe-
cifically expression of the ND6 mRNA, the only protein-coding
sequence located on the light-strand transcript. We show that
FASTK binds the light-strand precursor RNA at multiple sites
both within and downstream of the ND6-coding sequence and
that, together with the mitochondrial degradosome, it par-Cell Rticipates in generating the mature form of the ND6 mRNA. In
the absence of mitochondrial FASTK, the ND6 mRNA is unde-
tectable, resulting in decreased complex I activity in FASTK-
depleted cells and mice.
RESULTS
A Cryptic Mitochondrial-Targeting Signal in FASTK
The subcellular localization of FASTK in 143B cells and mouse
embryonic fibroblasts (MEFs) was investigated by immunoblot
analysis. Two bands of60 kDa and50 kDa could be detected
(Figures 1A and 1B), and both bands were absent in extracts
from 143B cells expressing an shRNA against FASTK or in
FASTK/ MEFs (Figures 1A and 1B). Subcellular fractionation
experiments indicated that the long form of FASTKwas enriched
in the cytosolic and nuclear fractions, whereas the short form
was enriched in mitochondria (Figure 1C). FASTK apparently
migrated more slowly in the nucleus, which could correlate
with phosphorylation of the protein (Tian et al., 1995), though
this was not investigated further in this study. In mitochondria,
FASTK was localized to the matrix as determined by the protein-
ase K accessibility test and is most likely attached to the inner
membrane because it remained associated with the membrane
fraction after alkali treatment (Figures 1D and 1E). Immunocyto-
logical staining of C-terminal HA-tagged FASTK (FASTK-HA)
using an antibody directed against the HA tag confirmed the
tripartite localization of FASTK in the nucleus, cytosol, and mito-
chondria and revealed the presence of foci in the organelle
(Figures 1F and 1G, left panel) reminiscent of the mitochondrial
RNA granules described previously (Jourdain et al., 2013).
Importantly, the two-band pattern of FASTK seen by western
blotting was also observed when FASTK-HA was expressed
exogenously (Figure 1F), indicating that a single FASTK mRNA
encodes two protein isoforms with different subcellular localiza-
tions (Figure 1H).
Several post-transcriptional mechanisms are able to generate
alternative protein isoforms from a single mRNA transcript. In the
case of FASTK, we were intrigued by the conserved in-frame
ATG at position 103 coding for methionine 35 (M35) (Figures
1H and S2A), because alternative translation initiation sites
have previously been shown to target proteins to different
cellular compartments, including mitochondria (Kazak et al.,
2013). To investigate the presence of an alternative start site in
FASTK, we mutated the second ATG (FASTK-HA M35G) and
observed that this mutation completely abolished the mitochon-
drial localization of the protein without affecting its cytosolic or
nuclear localization (Figure 1G, center panel). Furthermore,
immunoblot analysis revealed only the long form of FASTK,
whereas the short form was completely absent (Figure 1F). To
confirm these data directly, we constructed the N-terminally
truncated isoform of FASTK, which initiates at M35 (FASTK-HA
D1–34). After transfection into 143B cells, we found that
FASTK-HAD1–34was localized exclusively inmitochondria (Fig-
ure 1G, right panel). Immunoblot analysis of these cells showed
that the protein co-migrated with the short form of endogenous
FASTK (Figure 1F). These findings suggested that a cryptic mito-
chondrial-targeting sequence (MTS) may lie downstream of
M35. To test this, we fused the first 25 residues following M35eports 10, 1110–1121, February 24, 2015 ª2015 The Authors 1111
Figure 1. FASTK Is a Mitochondrial Protein
(A) Immunoblot analysis of 143B cells stably expressing an shRNA directed against FASTK. Membranes were probed with anti-FASTK and reprobed with
anti-PHB to verify equal sample loading.
(B) Immunoblot analysis of FASTK+/+ (WT) and FASTK/ (KO) MEFs. Membranes were probed as in (A).
(legend continued on next page)
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Figure 2. FASTK Co-localizes with Mitochondrial RNA Granules
(A) Confocal microscopy analysis of 143B cells stably expressing mitoFASTK-HA and mitoBFP, a mitochondrial-targeted version of the blue fluorescent protein.
Cells were incubated with 5 mM BrU for 1 hr before immunolabelling with anti-HA and anti-BrU/BrdU antibodies. Arrowhead, mitochondrial RNA granule.
(B) Confocal microscopy of 143B cells stably expressing mitoFASTK-HA and mitoBFP. Cells were immunolabelled with anti-HA and anti-GRSF1 antibodies.
Arrowhead, mitochondrial RNA granule.
(C) Confocal microscopy analysis of 143B cells stably expressing FASTKD2-HA and mitoBFP. Cells were incubated with 5 mM BrU for 1 hr before im-
munolabelling with anti-HA and anti-BrU/BrdU antibodies. Arrowhead, mitochondrial RNA granule.to GFP (FASTK 35-60-GFP) and observed that this sequence
was sufficient to target GFP to mitochondria (Figure S2B). Addi-
tional confirmation was obtained by mitochondrial import
studies in which we showed that in-vitro-translated FASTK-HA
D1–34, but not FASTK-HA M35G, could be imported into iso-
lated 143B mitochondria in a membrane-potential-dependent
manner (Figure S2C). Taken together, these data demonstrate
that FASTK can be translated from either the first initiation codon
(Figure 1H) to provide the cytosolic and nuclear forms of the pro-
tein (cytoFASTK) or from M35 to generate a shorter form that is
targeted to mitochondria (mitoFASTK).
FASTK Co-localizes with Mitochondrial RNA Granules
As mentioned above, the analysis of FASTK-HA by immunoflu-
orescence using an antibody to the HA tag revealed the pres-(C) Subcellular fractionation of 143B cells and analysis by western blotting show
branes were probed with antibodies directed against FASTK, and the purity of the
marker P54, and a mitochondrial marker mtSSB. Additional isoforms and modifi
(D) Immunoblot analysis of total isolated 143Bmitochondria (T), or supernatant (S)
Immunoblots were probed with antibodies against FASTK, PHB (a membrane m
(E) Immunoblot analysis of isolated 143B mitochondria after the proteinase K ac
membrane, or lysed in Triton X-100 prior to treatment with proteinase K. Immu
protein), anti-Tom20 (a mitochondrial outer membrane protein), and anti-mtSSB
(F) Immunoblot analysis of 143B cells stably expressing FASTK-HA, FASTK-HAM
with anti-HA antibody and then reprobed with anti-actin as a loading control
(G) Confocal microscopy of cells described in (F). Arrowheads indicate mitochon
(H) The FASTK gene showing the exon structure (1–10) and two ATG start site
methionine 35 (M35). FASTK protein can be translated from either site, but themito
at ATG 103. FAST_1, FAST_2, and RAP are the conserved domains of FASTK.
Cell Rence of mitochondrial-RNA-granule-like structures in the mito-
chondria of transfected cells (Figure 1G, left panel), and this
granular distribution was also seen in cells expressing mito-
FASTK-HA (Figure 1G, right panel). In previous studies, we
and others have shown that mitochondrial RNA granules accu-
mulate newly synthesized RNA and can be observed by BrU
labeling (Iborra et al., 2004; Jourdain et al., 2013), and we
thus assessed whether mitoFASTK-HA co-localized with
BrU-labeled granules in 143B cells. In cells stably expressing
mitoFASTK-HA, we found that 92% (n = 100) of foci contain-
ing FASTK were positive for BrU (Figure 2A) and that mito-
FASTK also co-localized with GRSF1, a component of the
mitochondrial RNA granules described previously (Figure 2B).
However, BrU incorporation and mitochondrial RNA granule
formation occurred normally in FASTK-depleted cellss a lower-molecular-weight isoform of FASTK present in mitochondria. Mem-
subcellular fractions was assessed using a cytosolic marker HSP90b, a nuclear
cation of FASTK in the nucleus or the cytosol were not investigated here.
and pellet (P) fractions after Na2CO3 (pH 11) extraction and ultra-centrifugation.
arker), or cytochrome c (Cyt c, a soluble marker).
cessibility test. Mitochondria were left untreated, swollen to rupture the outer
noblots were probed with anti-FASTK, anti-OPA1 (an inter-membrane space
(a matrix protein).
35G (cytoFASTK), or FASTK-HAD1–34 (mitoFASTK). Membranes were probed
drial RNA granules.
s at position 1, coding for methionine 1 (M1) and at position 103, coding for
chondrial targeting signal (M) of FASTK is exposed only when translation starts
eports 10, 1110–1121, February 24, 2015 ª2015 The Authors 1113
Figure 3. FASTK Is Required for NADH
Complex Activity
(A) Analysis of mitochondrial enzymatic activity on
quadriceps from FASTK+/+ (WT) and FASTK/
(KO) mice. Enzymatic activities were normalized
to the citrate synthase activity. Data from three
different mice are represented as mean ± SEM.
*p < 0.05 using a Mann-Whitney test; n = 3.
(B) A similar analysis to that shown in (A) was
performed on mouse hearts.
(C) Schematic representation of the mitochondrial
electron transport chain: I, NADH dehydrogenase
complex; II, succinate dehydrogenase com-
plex; III, cytochrome bc1 complex; IV, cytochrome
c oxidase complex. Q, ubiquinone/ubiquinol; C,
cytochrome c.
(D) Immunoblot analysis of FASTK+/+ (WT) and
FASTK/ (KO) hearts with the indicated anti-
bodies.(Figure S3A), suggesting that FASTK is not an essential struc-
tural component of the mitochondrial RNA granules. Of the
other members of the FASTK family, only FASTKD2 co-local-
ized with BrU foci (Figure 2B) whereas no co-localization
with RNA granules was observed for FASTKD1, FASTKD3,
FASTKD4 (TBRG4), or FASTKD5 (Figure S3B). Together, these
data indicate that the mitochondrial isoform of FASTK is a
component of mitochondrial RNA granules and that it is not
required for maintaining their structural integrity. The role of
FASTKD2 in mitochondrial RNA granules will be reported
elsewhere.
FASTK Is Required for Mitochondrial NADH
Dehydrogenase Activity
To test whether FASTK plays a role in mitochondrial function, we
took advantage of existing mice with a disrupted FASTK gene
(Simarro et al., 2010a). We first tested the enzymatic activity of
the respiratory chain complexes from the skeletal and cardiac
muscles of FASTK+/+ and FASTK/ animals and observed an
60% decrease in mitochondrial NADH dehydrogenase (com-
plex I) activity in both tissues, whereas the activity of other com-
plexes was not significantly altered or was even slightly
increased (Figures 3A–3C). The specific complex I deficiency1114 Cell Reports 10, 1110–1121, February 24, 2015 ª2015 The Authorswas confirmed by oxygraphy using two
independent FASTK+/+ and two indepen-
dent FASTK/ MEF lines (Figure S4).
Protein immunoblot analysis showed
that the steady-state levels of several
subunits of complex I, including
NDUFB8, NDUFS1, and NDUFS2, were
decreased in the heart of FASTK/ ani-
mals, suggesting a partial disassembly
of the complex as previously described
(Heide et al., 2012; Karamanlidis et al.,
2013), whereas subunits of the other
complexes were normally expressed
(Figure 3D). Thus, these results indicate
that FASTK is specifically required formitochondrial NADH dehydrogenase activity both in vitro and
in vivo.
FASTK Specifically Regulates ND6 mRNA Levels
Because FASTK is thought to bind RNA and is localized in the
mitochondrial RNA granules as shown above, we reasoned that
it may play a role in the post-transcriptional regulation of
mtDNA-encoded subunit(s) of the respiratory complex I. We
therefore performed a northern blot analysis to compare the
expression of these mRNAs in wild-type and FASTK/ cells.
MEFs isolated from FASTK/ animals showed a dramatic
reduction in the level of ND6 mRNA (MTND6), which encodes
subunit 6 of the NADH dehydrogenase complex, whereas all
other subunits of complex I were normally expressed (Fig-
ure 4A). Importantly, reintroduction of human mitoFASTK, but
not cytoFASTK, into FASTK/ MEFs restored MTND6 levels,
indicating that the regulation of MTND6 is under the control
of the mitochondrial form of FASTK (Figure 4B). We confirmed
the depletion of MTND6 in the brain, heart, muscle, and liver
from FASTK/ mice (Figure 4C). Similar results were obtained
using 143B cells in which FASTK was depleted by RNAi (Fig-
ure 4D). The level of all other mtDNA-encoded RNAs, including
the other 12 ORFs, was within the control range or slightly
Figure 4. FASTK Regulates ND6 mRNA Expression in Mitochondria
(A) Northern blot analysis of total RNA from FASTK+/+ (WT) and FASTK/ (KO) MEFs using riboprobes against all mitochondrial-encoded subunits of complex I.
(B) Northern blot and immunoblot analysis of FASTK+/+ (WT) and FASTK/ (KO) MEFs, in which GFP, FASTK-HA, mitoFASTK-HA (D1–34), or cytoFASTK-HA
(M35G) have been stably introduced.
(C) Northern blot analysis of total RNA from four different organs of FASTK+/+ (WT) and FASTK/ (KO) mice probed for the sequences indicated.
(D) Northern blot analysis of total RNA from 143B cells stably expressing an shRNA against FASTK, or the empty vector (pLKO), probed for the sequences
indicated.
(E) Northern blot analysis of total RNA from 143B cells stably expressing GFP or FASTK-HA using riboprobes directed against MTND6 or MTCO1.higher in FASTK-depleted cells and animals (Figures 4A, 4C,
and 4D). Strikingly, overexpression of human FASTK-HA in
143B cells led to the strong stabilization of ND6 mRNA, indi-
cating that FASTK is a limiting factor in the regulation of
MTND6 expression (Figure 4E). Taken together, our results indi-
cate that FASTK specifically controls the expression of ND6
mRNA in both cultured cells and mice.
The RAP Domain of FASTK Plays a Central Role in the
Regulation of ND6 mRNA
Among the conserved domains of the FASTK family, the RAP
domain has been predicted to bind RNA (Lee and Hong, 2004;
Figure 5A). This may explain the presence of the FASTK family
members in recent studies that identified mRNA-interacting pro-
teins (Baltz et al., 2012; Castello et al., 2012). Our data thus far
have demonstrated that FASTK regulates MTND6; therefore,
we investigated whether the two molecules could interact and
whether such an interaction may involve the RAP domain. For
this, we first generated 143B cells that stably expressed mito-
FASTK-HA and used these cells to perform immunoprecipitation
experiments using an antibody directed against the HA tag.
The immunoprecipitated RNAs were analyzed by dot-blotting
(RNA-IP) using riboprobes specific for MTND6 and several
other mitochondrial-encoded RNAs. As shown in Figure 5C (left
panel), we found that MTND6 was specifically enriched in the
mitoFASTK-HA immunoprecipitate, whereas none of the other
mitochondrial RNAs were detected. To test the role of the RAP
domain in mediating the interaction between FASTK and
MTND6, we generated a second line of 143B cells that stablyCell Rexpressed a mitoFASTK mutant lacking the RAP domain (mito-
FASTKDRAP-HA). mitoFASTKDRAP-HA expression did not pre-
vent the incorporation of BrU into newly synthesized RNA (Fig-
ure S3A). RNA-IP using these cells revealed that the interaction
of MTND6 with mutant FASTK was greatly reduced compared
to wild-type mitoFASTK (Figure 5C, right panel), even though
both versions of mitoFASTK were efficiently and selectively
precipitated by the anti-HA antibodies (Figure 5B). When in-
troduced into FASTK/ MEFs or into 143B cells depleted of
FASTK, mitoFASTKDRAP-HA could enter mitochondria (Fig-
ure 5E) but did not localize to mitochondrial RNA granules and
was not able to restore MTND6 expression (Figure 5D). Thus,
we conclude that FASTK interacts with MTND6 and that the
RAP domain is essential for this interaction. Deletion of the RAP
domain results in loss of the ND6-processing function of FASTK
and loss of its association with mitochondrial RNA granules.
The Mature ND6 mRNA Contains a 30 UTR
MTND6 is the only mRNA encoded by the light strand. The 50 end
of the protein-coding sequence is flanked by tRNAGlu (Fig-
ure S5A). However, there is no flanking downstream tRNA, and
the processing of its 30 end is thus an exception to the tRNApunc-
tuation model (Ojala et al., 1980). Instead, ND6mRNA is adjacent
to a long stretch of non-coding RNA that is complementary to
ND5 and is sometimes referred to as ‘‘mirror’’ ND5 (Figure S5A).
Indeed, there is no clear agreement regarding the length of
MTND6 30 UTR: whereas the original publication describing this
mRNA reported a coding sequence of 525 nucleotides followed
by a 30 UTR of 500–600 nucleotides (Ojala et al., 1980; Tulloeports 10, 1110–1121, February 24, 2015 ª2015 The Authors 1115
Figure 5. The RAP Domain of FASTK Is Required for Binding to ND6 mRNA and for FASTK Localization and Function
(A) Structural prediction of the RAP domain from FASTK according to I-TASSER. Details are given in Figure S1.
(B) Immunoblot analysis after immunoprecipitation with rabbit polyclonal antibodies directed against HA or FLAG (ctrl). Mitochondrial lysates for immunopre-
cipitationwere prepared from 143B cells expressing GFP,mitoFASTK-HA, or mitoFASTK-DRAP-HA. PHBwas used as a negative control. * indicates the IgG light
chain.
(C) RNA dot blot and quantification after immunoprecipitation as described in (B). Exposures shown here are made so that the ‘‘input’’ signal is comparable
between the different probes. Data are represented as mean ± SEM. n = 3.
(D) Northern blot analysis of FASTK+/+ (WT) and FASTK/ (KO) MEFs in which GFP, FASTK-HA, mitoFASTK-HA, or mitoFASTK-DRAP-HA have been stably
introduced.
(E) Confocal microscopy of 143B cells stably expressing mitoFASTK-DRAP-HA immunostained with antibodies directed against HA or Tom20, a mitochondrial
marker.et al., 1994; Slomovic et al., 2005; Ruzzenente et al., 2012), others
have reported that the 30 UTR of ND6 is only 33 to 34 nucleotides
(Mercer et al., 2011). We therefore decided to reassess this ques-
tion. Northern blots from wild-type and r0 cells were probed with
riboprobes directed against the coding sequence of ND6 (ribop-
robe: CDS) or against its putative long 30 UTR (riboprobe: UTR).
Both probes revealed the same major transcript of 1.0–1.1 kb
consistent with the original report, whereas several higher-molec-
ular-weight transcripts could also be discerned that were absent
in RNA from r0 cells (Figure S5B, black arrows).
FASTK Binds at Multiple Sites within the ND6
mRNA Precursor
Because FASTK is enriched in mitochondrial RNA granules, the
sites at which the newly synthesized RNAs are concentrated, we
wished to know whether FASTK could interact directly with the
ND6 mRNA and/or its precursors during MTND6 biogenesis.
First, to determine whether loss of FASTK affects the expression
of light-strand-encoded genes other than ND6, we performed1116 Cell Reports 10, 1110–1121, February 24, 2015 ª2015 The Authnorthern blotting using probes against tRNAPro, tRNAGlu, mirror
ND4/4L, or mirror COI (Figures 4D and S5C). No difference
was seen in the level of any of these transcripts in cells depleted
for FASTK, indicating that FASTK does not play a general role in
light-strand RNA metabolism. It is particularly noteworthy that
the level of tRNAGlu immediately upstream of ND6 is unaffected
(Figures 4D and S5D), which implies that FASTK does not partic-
ipate in 50 end processing of MTND6. To study processing of
the 30 end of MTND6, northern blots were exposed to a probe
directed against the non-coding RNA region corresponding to
mirror ND5 (Figures S5A and S5B). This probe revealed several
higher-molecular-weight species present at low levels and
possibly related to the higher-molecular-weight RNAs revealed
by the two ND6-specific probes (Figure S5B, arrows). These
RNAs likely represent the ND6 precursors described in the orig-
inal study and referred to as RNAs 1–3 (Ojala et al., 1980; Fig-
ure 6C, bottom). This therefore prompted us to test whether
FASTK could bind any of the ND6 precursors. To answer this
question, we repeated the RNA-IP as described in Figure 5ors
Figure 6. FASTK Binds the Precursors of ND6 mRNA
(A) RNA dot blot after immunoprecipitation using probes directed againstMTND6, mirror ND5, or MTCO1. The RNA-IP was performed in RNase-free conditions.
Exposures shown here are made so that the ‘‘input’’ signal is comparable between the different probes.
(B) Phosphorimager quantification of the data shown in (A). Data are represented as mean ± SEM. n = 3.
(C) IGV view of the RNA fragments bound to FASTK and aligned to the mitochondrial genome. The RNA-IP was partially digested with RNase I and sequenced
using next-generation RNA sequencing. Essentially no enrichment for heavy-strand transcripts was observed (rRNAs are considered as contaminants and are
enriched to the same extent in both IPs). In contrast, a strong enrichment of light-strand-encoded RNAswas observed specifically in the region encoding the ND6
transcripts. These results confirm the dot blotting shown in (A). Black arrowheads indicate sites of increased protection at the 30 ends of the ND6 mRNA and
precursor RNAs 1, 2, and 3 in the regions immediately preceding the 30 processing site. White arrowheads indicate the 30 processing sites for ND6 mRNA and
RNAs 1, 2, and 3, all of which are devoid of FASTK-mediated protection. Bottom: schematic representation of the mature ND6 mRNA and precursor RNAs 1–3.
Rectangles represent the ND6 coding sequence; lines represent non-coding sequences.
(D) Detailed view of the region corresponding to ND6 mRNA in (C). CDS: coding sequence. UTR: untranslated region.and probed the dot blots with the downstreammirror ND5 ribop-
robe. A significant increase in the signal was found in the mito-
FASTK-HA immunoprecipitate, indicating that FASTK binds to,
and is able to immunoprecipitate, the precursors of ND6
mRNA (Figures 6A and 6B). In order to refine our analysis of
the region bound by FASTK within the precursor RNA, we
repeated the RNA-IP and then performed a partial digestion
with RNase I and analyzed the protected RNA fragments using
next-generation RNA sequencing. Alignment of the sequences
obtained to the mitochondrial genome is shown in Figure 6C.
Apart from the presence of highly abundant rRNAs that are
also seen in the negative control, the results show that most of
the protected RNA fragments are transcribed from the DNA light
strand. No enrichment for heavy-strand RNAs was observed
(Figure 6C). The protected sequences covered the coding
sequence of ND6 mRNA, its 30 UTR, and to a lesser extent the
downstream sequences (Figures 6C and 6D).Cell RFASTK Modulates Degradosome Activity to Generate
the Mature ND6 mRNA
We next wished to investigate the RNase activity responsible
for depletion of MTND6 in the absence of FASTK. Light-strand
non-coding RNAs, or ‘‘mirror’’ RNAs, are normally eliminated
by the mitochondrial degradosome, which is composed of
the helicase hSuv3p, and the polynucleotide phosphorylase
PNPase, a 30-50 exoribonuclease (Borowski et al., 2013). Inter-
estingly, both the PNPase and hSuv3p are found in mitochon-
drial RNA granules (Borowski et al., 2013). Because MTND6 is
encoded on the light strand, we reasoned that this mRNA
could also be a substrate for the degradosome, and we there-
fore wished to investigate whether, in the absence of FASTK,
the degradosome could be responsible for the complete elim-
ination of MTND6. As previously reported, we found that
downregulation of either the PNPase or hSuv3p led to the
accumulation of mirror COI and mirror ND4/4L, whereas theeports 10, 1110–1121, February 24, 2015 ª2015 The Authors 1117
Figure 7. FASTK Modulates Degradosome
Activity to Generate the Mature ND6 mRNA
(A) Immunoblot analysis of 143B cells stably ex-
pressing an shRNA against either PNPase or
hSuv3p and probed with antibodies directed
against PNPase, hSuv3p, or GAPDH. pLKO cor-
responds to the empty vector.
(B) Immunoblot analysis of 143B cells stably ex-
pressing an shRNA against FASTK probed with
antibodies directed against the PNPase, hSuv3p,
or GAPDH. pLKO corresponds to the empty
vector.
(C) Northern blot analysis of cells stably express-
ing shRNAs against FASTK and/or the PNPase.
Parallel blots were probed to reveal MTND6 or
MTCO1. White arrowhead, matureMTND6. Black
arrowheads, MTND6-containing RNAs. pLKO
corresponds to the empty vector.
(D) Northern blot analysis of cells stably express-
ing shRNAs against FASTK and/or hSuv3p. Par-
allel blots were probed to reveal MTND6 and
MTCO1. White arrowhead, matureMTND6. Black
arrowheads, MTND6-containing RNAs. pLKO
corresponds to the empty vector.
(E) Proposed mechanism in which FASTK binds
the precursor forms of ND6 mRNA at multiple
sites, including the 30 UTR, and prevents its
degradation during processing of the light
strand by the mitochondrial degradosome. In the
absence of FASTK, uncontrolled activity of the
degradosome leads to complete elimination of
the entire ND6 mRNA (see Discussion for more
details). CDS: coding sequence. UTR: untrans-
lated region. ncNA: non-coding RNA.heavy-strand transcripts, MTCOI and 12S, were not at all or
only mildly affected (Figures 7C, 7D, and S5C). Interestingly,
depletion of either component of the degradosome also led
to the strong accumulation of ND6-containing transcripts (Fig-
ures 7C and 7D lines 1 and 2, black arrowheads), suggesting
that the degradosome is also involved in the generation of
MTND6. To find out whether activity of the degradosome could
be responsible for the loss of MTND6 in the absence of FASTK,
we depleted both FASTK and the PNPase or hSuv3p. As ex-
pected, MTND6 was not detected in cells depleted for FASTK
alone. However, when the degradosome activity was also1118 Cell Reports 10, 1110–1121, February 24, 2015 ª2015 The Authorsimpaired, we found a considerable in-
crease in ND6-containing transcripts of
various sizes, although significantly no
accumulation of mature MTND6, indi-
cating that the degradosome is respon-
sible for MTND6 degradation in the
absence of FASTK. In control experi-
ments, we showed that the abundance
of the degradosome subunits was not
affected by the depletion of FASTK
(Figure 7B). Based on these data, we
conclude that the degradosome partici-
pates in the processing of the light-
strand-encoded RNAs and is largelyresponsible for the depletion of MTND6 in the absence of
FASTK.
DISCUSSION
In this report, we have studied the RNA-binding protein
FASTK, a protein previously found to be associated with
RNA granules in the nucleus and cytoplasm. Here, we report
the existence of a translational variant of FASTK that is tar-
geted to mitochondria, where it co-localizes with the mito-
chondrial RNA granules. We provide evidence that the
mitochondrial form of FASTK binds ND6 mRNA and its pre-
cursors and that it cooperates with the mitochondrial degra-
dosome to regulate ND6 mRNA biogenesis. Accordingly, we
found that depletion of FASTK results in the loss of mature
ND6 mRNA, leading to reduced complex I activity in both
cultured cells and mice.
Regulation of ND6 mRNA Biogenesis by the
Mitochondrial Isoform of FASTK
FASTK was previously reported to localize to speckles in the nu-
cleus and to P-bodies and stress granules in the cytoplasm (Ke-
dersha et al., 2005; Simarro et al., 2007). We have now identified
a second translation initiation site in the FASTK mRNA immedi-
ately upstream of a cryptic MTS. Use of this alternative start
site generates a shorter protein that is localized to mitochondria,
where it concentrates in the mitochondrial RNA granules. The
existence of a cryptic MTS is not exclusive to FASTK, and similar
sequences have recently been described for several other pro-
teins (Kazak et al., 2013), suggesting that internal initiation of
translation upstream of a specific targeting sequence may pro-
vide a general mechanism by which a single mRNA is able to
generate different isoforms destined for localization to distinct
subcellular compartments.
We report that the mitochondrial form of FASTK is involved
specifically in the regulation of ND6 mRNA. Interestingly,
whereas depletion of FASTK resulted in loss ofMTND6, overex-
pression of the protein led to significant increase in this mRNA
compared to control cells (Figure 4E), suggesting that binding
to FASTK is a rate-limiting step in the control of ND6 mRNA
levels. MTND6 is unique in being the only protein-coding tran-
script encoded on the light strand of the mitochondrial genome.
It is also an exception to the tRNA punctuation model, because
there is no tRNA adjacent to the 30 end of the coding sequence,
and indeed MTND6 is one of the rare mitochondrial RNAs that
has an extended 30 UTR and that, at steady state, also exists
in the form of several higher-molecular-weight precursors previ-
ously referred to as RNAs 1–3 (Ojala et al., 1981). Our analysis of
the RNA sequences bound to FASTK following partial RNase
digestion showed that FASTK binds specifically light-strand-en-
coded RNAs and protects in particular the ND6 mRNA-coding
sequence and its 30 UTR (Figure 6D). Very little is known about
the processing of the light-strand precursor RNA, which also
contains the non-coding so-called ‘‘mirror’’ sequences. In previ-
ous work, it was reported that the mirror RNAs are degraded by
the degradosome and that they accumulate when either the
PNPase or the helicase hSuv3p components of the degrado-
some are depleted (Szczesny et al., 2010; Borowski et al.,
2013). We have confirmed these results and have extended
our analysis of degradosome activity to include its role in expres-
sion ofMTND6.We observed thatMTND6-containing transcripts
also accumulate in the absence of PNPase or hSuv3p (Figures
7C and 7D), indicating that, like the mirror RNAs, MTND6 levels
are regulated by the degradosome. Mitochondrial mRNAs en-
coded on the heavy strand, however, such as MTCOI, were
insensitive to depletion of the degradosome (Figure S5C). Strik-
ingly, in cells depleted for FASTK, we could restore expression
of MTND6-containing transcripts by depletion of PNPase or
hSuv3p (Figures 7C and 7D, lanes 3 and 4). However, in thisCell Rcase, we observed no enrichment for the 1.0–1.1 kb transcript
corresponding to the mature ND6 mRNA. This result suggests
first that FASTK protects MTND6 from the degradosome and
second that it is involved in defining the length of the mature
mRNA. Taken together with the observations that (1) only
the 50 end of the ND6 mRNA is defined by tRNA excision; (2)
FASTK binds at multiple sites along MTND6, and (3) the region
downstream of ND6 encodes ‘‘mirror’’ RNAs that are normally
eliminated by the degradosome, we have proposed a model
shown in Figure 7E, in which binding to FASTK defines the length
and the abundance of MTND6 by regulating the processing ac-
tivity of the degradosome. Thus, in the absence of FASTK, the
unbound ND6 mRNA is completely eliminated by the degrado-
some, whereas in the absence of both FASTK and an active de-
gradosome, high-molecular-weight, ND6-containing precursor
RNAs accumulate, although the mature ND6 mRNA of 1.0–
1.1 kb is not generated. We propose that binding of FASTK is
a rate-limiting step in controlling the abundance of MTND6
because its depletion leads to loss of MTND6 and its overex-
pression results in the stabilization of this mRNA (Figure 4). A
similar process has recently been described in chloroplasts
where certain pentatricopeptide-repeat (PPR) proteins partici-
pate in a ‘‘barrier’’ mechanism in which the protein binds directly
to the 30 end of a mRNA, blocking its degradation by the 30-50
PNPase activity (Barkan and Small, 2014). Although several
PPR proteins have been identified in human mitochondria,
including POLRMT or the PTCD1–3, to our knowledge none of
them play a role in the stability of MTND6. On the other hand,
FASTK is predicted to share a similar global architecture to
PPR proteins, including the repeated a helix motifs (Figure S1B),
and indeed FASTK has previously been referred to as an ‘‘octo-
tricopeptide-repeat’’ (OPR) protein (Eberhard et al., 2011).
Furthermore, it is interesting that a RAP-domain-containing pro-
tein has very recently been identified in chloroplasts ofArabidop-
sis, which, in a manner analogous to FASTK, has been shown to
bind to and regulate the processing of the 12S rRNA (Kleinknecht
et al., 2014). Thus, in widely divergent species, FASTK and
FASTK-related proteins appear to be part of a conserved mech-
anism involved in the biogenesis of organellar RNAs.
Functional Relevance of the Loss of FASTK
The ND6 protein is thought to be a key component of the respi-
ratory chain complex I because a nonsensemutation in this gene
leads to complex I disassembly (Bai and Attardi, 1998). In agree-
ment with these findings, we found an 60% loss of complex I
activity in different tissues from FASTK/ animals (Figures 3A
and 3B), and this was accompanied by a concomitant decrease
in the level of several nuclear-encoded subunits of complex I
(Figure 3D), also indicating a partial disassembly of the complex.
The decrease in NADH dehydrogenase activity however was not
as strong as we might have expected from the dramatic deple-
tion of ND6 mRNA. This could indicate either that ND6 does
not play the critical role in complex I assembly that had been pre-
viously proposed (Deng et al., 2006) or that low-level residual
ND6 mRNA is able to produce sufficient ND6 protein to permit
some complex I activity (Perales-Clemente et al., 2011). Unfor-
tunately, in the absence of good commercially available anti-
bodies against ND6 (Perales-Clemente et al., 2011), we haveeports 10, 1110–1121, February 24, 2015 ª2015 The Authors 1119
not been able to distinguish between these possibilities in our
experiments.
In conclusion, we have described a novel component of the
mitochondrial RNA granules, FASTK, which is essential for
MTND6 expression.We propose amodel that predicts that bind-
ing of FASTK to the MTND6 transcript blocks the activity of the
degradosome and participates in delineating its 30 end. Intrigu-
ingly, FASTK is localized in several other types of RNA granules,
including P-bodies and stress granules that appear to play
diverse roles in post-transcriptional regulation of mRNA, in-
cluding mRNA modification and degradation (Anderson and Ke-
dersha, 2009). It is tempting to speculate that similar processes
occur in the mitochondrial RNA granules where FASTK ensures
the regulated expression of the ND6 mRNA.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
All cell culture reagents were from GE Healthcare. Cells were cultured in
DMEM supplemented with 10% heat-inactivated fetal bovine serum,
100 u/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine. When
143B r0 were used, the culture medium was further supplemented with
110 mg/ml pyruvate and 50 mg/ml uridine. Transfections were performed using
calcium phosphate or Fugene (Roche).
Bromouridine Staining, Immunofluorescence, and Microscopy
BrU staining, immunofluorescence, and microscopy were performed as previ-
ously described (Jourdain et al., 2013). Briefly, BrU staining was performed by
incubating cells for 1 hr with 5 mM BrU (Sigma-Aldrich) and immunostaining
with anti-BrU/BrdU (Roche) was performed in PBS containing 0.1% Triton
X-100 and 3%w/v BSA (Sigma-Aldrich). Imaging was performed using a Zeiss
LSM700 confocal microscope. All antibodies used are described in Table S1.
RNA Extraction and Northern Blotting
RNA extraction and northern blot analyses were performed as previously
described (Jourdain et al., 2013). Briefly, total RNA was extracted with Tri Re-
agent (Sigma-Aldrich) and GlycoBlue (Ambion). 5–15 mg RNA were separated
on a denaturing formaldehyde agarose gel and transferred electrophoretically
to a Nylon membrane (GE Healthcare). Strand-specific radiolabelled ribop-
robes (Table S1) were transcribed in vitro using T7 polymerase (Bio-Rad) in
the presence of 32P-UTP, and hybridization was performed at 60C in 50%
formamide, 7% SDS, 0.2M NaCl, 80 mM sodium phosphate (pH 7.4), and
100 mg/ml salmon sperm DNA. Imaging was done with a phosphorimager
(Bio-Rad).
Mitochondria-Rich Fraction Isolation, Protein Import, Proteinase K
Accessibility Test, and Alkali Treatment
Preparation of cytosolic, nuclear, and mitochondria-rich fractions; protein
import assays; proteinase K accessibility testing; and alkali treatment were
performed as described previously (Jourdain et al., 2013).
Immunoprecipitation, Partial RNase Digestion, and RNA Sequencing
A mitochondria-rich fraction was isolated form 143B cells stably expressing a
C-terminal tagged version of the gene of interest and resuspended in IP buffer
(50 mM Tris/HCl [pH 7.5], 150 mM NaCl, 1 mM MgCl2, 1% NP-40, 3 mM va-
nadylate RNase complex, and 400 u/ml RNAsin Plus [Promega]). Protein-G-
coated Dynabeads (Invitrogen) were washed and incubated in the same buffer
with polyclonal anti-HA (Abcam) or polyclonal anti-FLAG (Sigma-Aldrich).
Beadswere thenwashed, themitochondrial lysatewas added, and themixture
was incubated overnight at 4C. For partial RNase treatment, beads were
washed twice and incubated for 5min at 37Cwith 0.2 u/ml of RNase I (Ambion)
in IP buffer without RNase, vanadylate, and RNAsin. After extensive washing,
the tubes were changed and the digested RNAs were 30 dephosphorylated on
beads for 20 min at 37C using polynucleotide kinase (PNK; Promega) in1120 Cell Reports 10, 1110–1121, February 24, 2015 ª2015 The Authabsence of ATP. 50 phosphorylation was achieved by incubating the RNAs
with PNK in presence of ATP for 10 min according to the manufacturer’s in-
structions, before RNA extraction. Quality control, RNA size profiling to ensure
correct RNase I digestion, library preparation, and Illumina MiSeq 1 3 50
sequencing were performed at Fasteris (Plan-les-Ouates). Sequences were
mapped to the human genome (hg38) using Bowtie. The sequences were
aligned to the human mitochondrial genome (NC_012920), visualized and
quantified with IGV (Broad Institute).
Cloning, Viral Production, and RNAi
For protein expression, cDNAs were cloned in pCi (Promega) in frame with a
C-terminal HA-TEV-6HIS tag. Primers are described in Table S1. cDNAs
were then subcloned into pWPT with the following primers: fwd: ATC GAT
CGA CGC GTA CTT AAT ACG ACT CAC TAT AG; rev: CGA TCG ATG TCG
ACA ATG TAT CTT ATC ATG TCT GCT C using MluI and SalI restriction en-
zymes. Lentiviruses for protein expression were produced in 293T HEK by
co-transfecting the constructs of interest cloned into the pWPT vector with
the viral plasmids psPAX2 and pMD2G (Addgene). After 2 days, the superna-
tant was collected, filtered at 0.45 mm, and used to infect 143B cells. shRNA
sequences were supplied precloned in either pLKO.1 (Sigma) or pLKO-TetON
(Addgene; Table S1), and the same protocol of lentivirus production was used.
After infection for >24 hr, cells were selected with 3 mg/ml puromycin (Sigma)
overnight and were analyzed >24 hr after addition of puromycin. pLKO-TetON
is a tetracycline-inducible version of pLKO.1 and was induced with 1 mg/ml of
doxycycline for 3–5 days. pLKO.1 or pLKO-TetON empty vectors were always
included as negative controls.
Mitochondrial Enzymatic Activities and Respiration Rates
Please refer to the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.01.063.
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